CATALOGO DEI PRODOTTI DELLA RICERCA

CETTO, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.701
EU - Europa 7.557
AS - Asia 5.306
SA - Sud America 803
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 13
Totale 23.557
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.532
RU - Federazione Russa 2.483
SG - Singapore 2.303
GB - Regno Unito 1.602
CN - Cina 1.589
IT - Italia 785
BR - Brasile 639
SE - Svezia 614
FR - Francia 472
IE - Irlanda 446
FI - Finlandia 438
VN - Vietnam 396
HK - Hong Kong 394
DE - Germania 372
KR - Corea 166
UA - Ucraina 113
CA - Canada 95
IN - India 87
BD - Bangladesh 62
AR - Argentina 51
TR - Turchia 51
JP - Giappone 42
BE - Belgio 38
ES - Italia 32
IR - Iran 32
MX - Messico 32
NL - Olanda 29
IQ - Iraq 25
NG - Nigeria 25
ZA - Sudafrica 25
PL - Polonia 24
EC - Ecuador 22
IL - Israele 21
CO - Colombia 20
VE - Venezuela 20
ID - Indonesia 19
UZ - Uzbekistan 18
MA - Marocco 17
LT - Lituania 16
PK - Pakistan 16
CL - Cile 14
EG - Egitto 14
AT - Austria 13
JM - Giamaica 13
PY - Paraguay 13
AU - Australia 10
NP - Nepal 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
UY - Uruguay 9
AL - Albania 8
LV - Lettonia 8
PH - Filippine 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
NI - Nicaragua 7
AZ - Azerbaigian 6
BO - Bolivia 6
HN - Honduras 6
JO - Giordania 6
MY - Malesia 6
PE - Perù 6
BY - Bielorussia 5
PT - Portogallo 5
SN - Senegal 5
AM - Armenia 4
DK - Danimarca 4
ET - Etiopia 4
EU - Europa 4
KE - Kenya 4
PS - Palestinian Territory 4
TW - Taiwan 4
AO - Angola 3
GR - Grecia 3
GY - Guiana 3
KG - Kirghizistan 3
NO - Norvegia 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
ML - Mali 2
MN - Mongolia 2
OM - Oman 2
PR - Porto Rico 2
PW - Palau 2
TT - Trinidad e Tobago 2
Totale 23.475
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.418
Southend 1.350
Singapore 1.185
Ashburn 1.119
Chandler 801
Moscow 772
San Jose 747
Dallas 619
Dublin 446
Woodbridge 446
Hong Kong 385
Council Bluffs 380
Ann Arbor 296
Houston 291
The Dalles 240
Beijing 212
Verona 199
New York 166
Princeton 164
Lawrence 163
Los Angeles 161
Wilmington 154
Ho Chi Minh City 146
Nanjing 119
Jinan 115
Shenyang 109
Buffalo 98
Las Vegas 98
São Paulo 98
Hanoi 95
Hebei 89
Milan 86
Tianjin 81
Helsinki 79
Santa Clara 61
Orem 56
Zhengzhou 53
Ningbo 51
Boardman 50
Haikou 44
Nanchang 44
Hangzhou 43
Changsha 42
Sindelfingen 41
Munich 38
Tokyo 38
Brussels 37
Chennai 37
Taizhou 34
Toronto 34
Chicago 33
Redondo Beach 33
Jiaxing 31
Rome 31
Turku 31
Guangzhou 30
Lancaster 29
Montreal 28
Rio de Janeiro 27
Columbus 26
Norwalk 26
Seattle 26
Abuja 24
Brooklyn 23
Fairfield 23
Falls Church 23
Annandale 21
Philadelphia 21
Phoenix 21
Taiyuan 21
Amsterdam 19
Da Nang 19
Fuzhou 19
Denver 18
Atlanta 17
Mexico City 17
Warsaw 17
London 16
Manchester 16
Tashkent 16
Frankfurt am Main 15
Providence 15
Boston 14
Belo Horizonte 13
Brasília 13
Istanbul 13
Lanzhou 13
San Francisco 13
Stockholm 13
Kent 12
Parma 12
Falkenstein 11
Guarulhos 11
Johannesburg 11
Poplar 11
Queens 11
Curitiba 10
Dearborn 10
Haiphong 10
Kingston 10
Totale 14.573
Salva come PNG Salva come JPEG
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 308
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 268
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 264
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 249
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 245
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 237
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 235
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 235
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 233
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 227
Gamma Knife radiosurgery in brain metastases from testicular tumors 221
A feasibility study for an hospital-based breast cancer registry. 219
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 218
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 214
Analisi di linkage in famiglie con carcinoma mammario ereditario. 213
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 211
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 210
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 208
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 208
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 205
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 202
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 200
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 200
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 196
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 196
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 191
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 189
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 188
Current trends in hematopoietic stem cell transplantation in Europe 187
[Idiopathic aneurysm of the right ventricle. Report of a case] 186
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 186
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 185
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 183
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 179
Comparative analysis of three different methods in detecting breast cells in bone marrow. 179
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 178
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 177
Terminal transferase expression in relapsed acute myeloid leukaemia 176
Cisplatin pharmacokinetics in elderly patients 176
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 176
Caratterizzazione di una nuova linea cellulare di melanoma umano. 176
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97. 176
Anemia, cancro e chemioterapia antiblastica. 175
Anemia, cancro e chemioterapia antiblastica. 174
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 174
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 174
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 173
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 173
A good death for cancer patients:still a dream? 171
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 170
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 169
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 168
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 165
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 165
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 164
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 164
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 162
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 161
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 161
Gram-negative septicemia in patients with hematologic malignancies 160
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 159
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 159
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 158
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 158
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 157
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 157
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 156
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 156
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 155
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 153
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 151
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 149
Fanconi's anaemia in adults: study of three families 144
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 144
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 143
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 140
Efficacia antiemetica dell'ondansetron (GR 38032): continuità dell'attività terapeutica. 139
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 138
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 138
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 135
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 135
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 131
Bone marrow micrometastases in breast cancer patients. 129
Micrometastases in bone marrow in breast cancer patients. 128
Bone metastases from primary cardiac sarcoma: case report 128
Micrometastases in bone marrow: study in 51 breast cancer patients. 127
Chemotherapy for metastatic melanoma 126
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 125
Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. 125
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 124
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 123
Ifosfamide encephalopathy: a case report 123
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 123
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 123
Significato Prognostico dei recettori per estrogeni (RE) e per progesterone (RP) nel cancro mammario. 123
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 121
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 121
Kinetic of cisplatin in a five day schedule during repetitive courses of chemotherapy. 120
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 116
Comparison of two different methods of evaluating proliferative index in breast cancer. 116
Totale 17.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.415
article - articoli 33.211
book - libri 3.290
conference - conferenze 40.914
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022923 0 0 0 204 78 37 33 76 64 31 127 273
2022/20232.534 203 216 270 361 345 624 23 141 269 18 45 19
2023/20241.043 39 114 89 113 146 150 39 39 5 48 168 93
2024/20253.050 179 216 96 489 148 56 163 106 508 220 211 658
2025/20268.079 637 529 558 1.372 2.005 459 714 392 664 421 81 247
2026/20271.402 83 238 503 578 0 0 0 0 0 0 0 0
Totale 23.557